These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 20523012

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Synthesis and mechanistic evaluation of novel N'-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents.
    Lourenço AL, Salvador RRS, Silva LA, Saito MS, Mello JFR, Cabral LM, Rodrigues CR, Vera MAF, Muri EMF, de Souza AMT, Craik CS, Dias LRS, Castro HC, Sathler PC.
    Eur J Med Chem; 2017 Jul 28; 135():213-229. PubMed ID: 28453995
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antiplatelet pyrazolopyridines derivatives: pharmacological, biochemical and toxicological characterization.
    Saito MS, Lourenço AL, Dias LR, Freitas AC, Vitorino MI, Albuquerque MG, Rodrigues CR, Cabral LM, Dias EP, Castro HC, Satlher PC.
    J Enzyme Inhib Med Chem; 2016 Dec 28; 31(6):1591-601. PubMed ID: 27000933
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM, Jin HS, Sun LP, Piao HR, Quan ZS.
    Bioorg Med Chem Lett; 2005 Nov 15; 15(22):5027-9. PubMed ID: 16169724
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis and pharmacological evaluation of novel pyrazolo[3,4-b]thieno[2,3-d]pyridine acid derivatives: a new class of anti-inflammatory and anti-platelet agents.
    Cardoso CR, de Brito FC, da Silva KC, de Miranda AL, Fraga CA, Barreiro EJ.
    Bioorg Med Chem Lett; 2002 Jan 07; 12(1):9-12. PubMed ID: 11738562
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin.
    Binsaleh NK, Wigley CA, Whitehead KA, van Rensburg M, Reynisson J, Pilkington LI, Barker D, Jones S, Dempsey-Hibbert NC.
    Eur J Med Chem; 2018 Jan 01; 143():1997-2004. PubMed ID: 29129512
    [Abstract] [Full Text] [Related]

  • 10. Structure⁻Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic Diseases.
    Yang CH, Hsia CW, Jayakumar T, Sheu JR, Hsia CH, Khamrang T, Chen YJ, Manubolu M, Chang Y.
    Int J Mol Sci; 2018 Nov 19; 19(11):. PubMed ID: 30463221
    [Abstract] [Full Text] [Related]

  • 11. New 1H-pyrazole-4-carboxamides with antiplatelet activity.
    Rehse K, Kotthaus J, Khadembashi L.
    Arch Pharm (Weinheim); 2009 Jan 19; 342(1):27-33. PubMed ID: 19051198
    [Abstract] [Full Text] [Related]

  • 12. THE SEARCH OF COMPOUNDS WITH ANTIAGGREGATION ACTIVITY AMONG S-ESTERS OF THIOSULFONIC ACIDS.
    Halenova TI, Nikolaeva IV, Nakonechna AV, Bolibrukh KB, Monka NY, Lubenets VI, Savchuk OM, Novikov VP, Ostapchenko LI.
    Ukr Biochem J; 2015 Jan 19; 87(5):83-92. PubMed ID: 26717599
    [Abstract] [Full Text] [Related]

  • 13. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC, Kummerle AE, Lugnier C, Fraga CA, Barreiro EJ, Miranda AL.
    Eur J Pharmacol; 2010 Jul 25; 638(1-3):5-12. PubMed ID: 20412790
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Design, synthesis of novel tryptophan derivatives for antiplatelet aggregation activity based on tripeptide pENW (pGlu-Asn-Trp).
    Xie Z, Feng S, Wang Y, Cao C, Huang J, Chen Y, Kong Y, Li Z.
    Eur J Med Chem; 2015 Sep 18; 102():363-74. PubMed ID: 26298494
    [Abstract] [Full Text] [Related]

  • 16. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
    Amidi S, Esfahanizadeh M, Tabib K, Soleimani Z, Kobarfard F.
    ChemMedChem; 2017 Jun 21; 12(12):962-971. PubMed ID: 28494138
    [Abstract] [Full Text] [Related]

  • 17. Synthesis, antiplatelet and in silico evaluations of novel N-substituted-phenylamino-5-methyl-1H-1,2,3-triazole-4-carbohydrazides.
    Jordão AK, Ferreira VF, Lima ES, de Souza MC, Carlos EC, Castro HC, Geraldo RB, Rodrigues CR, Almeida MC, Cunha AC.
    Bioorg Med Chem; 2009 May 15; 17(10):3713-9. PubMed ID: 19380229
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, in vitro cytotoxicity and biological evaluation of twenty novel 1,3-benzenedisulfonyl piperazines as antiplatelet agents.
    Liu XJ, Wang Y, Wang X, Zhang ZH.
    Bioorg Med Chem; 2021 Sep 15; 46():116390. PubMed ID: 34500186
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and pharmacological evaluation of novel beta-nitrostyrene derivatives as tyrosine kinase inhibitors with potent antiplatelet activity.
    Wang WY, Hsieh PW, Wu YC, Wu CC.
    Biochem Pharmacol; 2007 Aug 15; 74(4):601-11. PubMed ID: 17601492
    [Abstract] [Full Text] [Related]

  • 20. Synthesis and antiplatelet activity of new imidazole-4-carboxylic acid derivatives.
    Rehse K, Steege J.
    Arch Pharm (Weinheim); 2005 Nov 15; 338(11):539-47. PubMed ID: 16281307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.